Does Rallies track congressional trades in COR?

Yes. Rallies tracks politician and congressional stock disclosures for COR, including reported purchases, sales, dates, owners, and trade amounts when available.

Is COR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.

COR (Cencora, Inc.) Stock Analysis - Politician Trades

Cencora, Inc. (COR) is a publicly traded Healthcare sector company. As of May 20, 2026, COR trades at $262.65 with a market cap of $50.95B and a P/E ratio of 20.19. COR moved -0.54% today. Year to date, COR is -22.34%; over the trailing twelve months it is -9.62%. Its 52-week range spans $218.65 to $377.54. Analyst consensus is strong buy with an average price target of $358.40. Rallies surfaces COR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded COR stock?

Recent politician trading activity in COR includes disclosures from Jefferson Shreve, Michael McCaul, Michael McCaul, Greg Landsman, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

COR Key Metrics

Key financial metrics for COR
Metric	Value
Price	$262.65
Market Cap	$50.95B
P/E Ratio	20.19
EPS	$13.12
Dividend Yield	0.60%
52-Week High	$377.54
52-Week Low	$218.65
Volume	1.65M
Avg Volume	0
Revenue (TTM)	$328.68B
Net Income	$2.55B
Gross Margin	3.81%

Congressional Trades in COR

Jefferson Shreve sale COR on May 12, 2025 (amount: $100.00K).
Michael McCaul purchase COR on Oct 9, 2024 (amount: $100.00K) for Spouse.
Michael McCaul purchase COR on Oct 9, 2024 (amount: $50.00K).
Greg Landsman purchase COR on May 29, 2024 (amount: $50.00K) for Spouse.
Thomas R. Carper sale (full) COR on Nov 16, 2021 (amount: $15.00K) for Spouse.

Latest COR News

Cencora slides as Q2 adjusted EPS and cash flow miss overshadow raised outlook — May 6, 2026
Cencora drops as Walgreens early-settles forward trades and sells COR shares — Apr 21, 2026
McKesson EPS up 19.6% Drives 144% Return, Shifts Focus to Oncology — Apr 20, 2026
Cencora drops 3% as opioid-settlement costs and profit-taking pressure shares — Apr 10, 2026
Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion — Mar 23, 2026

Recent COR Insider Trades

Mauch Robert P. sold 3.76K (~$1.35M) on Feb 20, 2026.
Mauch Robert P. sold 1.33K (~$479.16K) on Feb 18, 2026.
Mauch Robert P. sold 5.10K (~$1.81M) on Jan 20, 2026.

COR Analyst Consensus

11 analysts cover COR: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $358.40.

Common questions about COR

Which politicians traded COR stock?: Recent politician trading activity in COR includes disclosures from Jefferson Shreve, Michael McCaul, Michael McCaul, Greg Landsman, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in COR?: Yes. Rallies tracks politician and congressional stock disclosures for COR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is COR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.